Logo image of ALHC

ALIGNMENT HEALTHCARE INC (ALHC) Stock Fundamental Analysis

NASDAQ:ALHC - Nasdaq - US01625V1044 - Common Stock - Currency: USD

16.11  +0.42 (+2.68%)

Fundamental Rating

3

ALHC gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 109 industry peers in the Health Care Providers & Services industry. ALHC has a bad profitability rating. Also its financial health evaluation is rather negative. ALHC is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ALHC had negative earnings in the past year.
ALHC had a positive operating cash flow in the past year.
In the past 5 years ALHC always reported negative net income.
In multiple years ALHC reported negative operating cash flow during the last 5 years.
ALHC Yearly Net Income VS EBIT VS OCF VS FCFALHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M

1.2 Ratios

With a Return On Assets value of -16.37%, ALHC is not doing good in the industry: 78.50% of the companies in the same industry are doing better.
ALHC has a worse Return On Equity (-128.23%) than 82.24% of its industry peers.
Industry RankSector Rank
ROA -16.37%
ROE -128.23%
ROIC N/A
ROA(3y)-21.65%
ROA(5y)-20.54%
ROE(3y)-95.11%
ROE(5y)-84.8%
ROIC(3y)N/A
ROIC(5y)N/A
ALHC Yearly ROA, ROE, ROICALHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 50 -50 -100

1.3 Margins

ALHC has a worse Gross Margin (10.97%) than 77.57% of its industry peers.
In the last couple of years the Gross Margin of ALHC has declined.
ALHC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 10.97%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.14%
GM growth 5Y-2.77%
ALHC Yearly Profit, Operating, Gross MarginsALHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 10 -10

More info and screens

3

2. Health

2.1 Basic Checks

ALHC does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALHC has more shares outstanding than it did 1 year ago.
ALHC has more shares outstanding than it did 5 years ago.
ALHC has a worse debt/assets ratio than last year.
ALHC Yearly Shares OutstandingALHC Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
ALHC Yearly Total Debt VS Total AssetsALHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 4.35 indicates that ALHC is not in any danger for bankruptcy at the moment.
ALHC has a better Altman-Z score (4.35) than 80.37% of its industry peers.
A Debt/Equity ratio of 3.22 is on the high side and indicates that ALHC has dependencies on debt financing.
With a Debt to Equity ratio value of 3.22, ALHC is not doing good in the industry: 80.37% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 3.22
Debt/FCF N/A
Altman-Z 4.35
ROIC/WACCN/A
WACC8.95%
ALHC Yearly LT Debt VS Equity VS FCFALHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 1.88 indicates that ALHC should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.88, ALHC is in the better half of the industry, outperforming 69.16% of the companies in the same industry.
ALHC has a Quick Ratio of 1.88. This is a normal value and indicates that ALHC is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.88, ALHC is in the better half of the industry, outperforming 71.03% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.88
Quick Ratio 1.88
ALHC Yearly Current Assets VS Current LiabilitesALHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

7

3. Growth

3.1 Past

ALHC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.82%, which is quite good.
The Revenue has grown by 48.25% in the past year. This is a very strong growth!
Measured over the past years, ALHC shows a very strong growth in Revenue. The Revenue has been growing by 28.99% on average per year.
EPS 1Y (TTM)12.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%36%
Revenue 1Y (TTM)48.25%
Revenue growth 3Y32.29%
Revenue growth 5Y28.99%
Sales Q2Q%50.68%

3.2 Future

Based on estimates for the next years, ALHC will show a very strong growth in Earnings Per Share. The EPS will grow by 27.53% on average per year.
Based on estimates for the next years, ALHC will show a very strong growth in Revenue. The Revenue will grow by 23.58% on average per year.
EPS Next Y24.25%
EPS Next 2Y18.4%
EPS Next 3Y29.96%
EPS Next 5Y27.53%
Revenue Next Year29.89%
Revenue Next 2Y26.48%
Revenue Next 3Y23.74%
Revenue Next 5Y23.58%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ALHC Yearly Revenue VS EstimatesALHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B
ALHC Yearly EPS VS EstimatesALHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 -0.5 -1

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALHC. In the last year negative earnings were reported.
Also next year ALHC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALHC Price Earnings VS Forward Price EarningsALHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALHC Per share dataALHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

ALHC's earnings are expected to grow with 29.96% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y18.4%
EPS Next 3Y29.96%

More info and screens

0

5. Dividend

5.1 Amount

ALHC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ALIGNMENT HEALTHCARE INC

NASDAQ:ALHC (3/3/2025, 1:29:09 PM)

16.11

+0.42 (+2.68%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-27 2025-02-27/amc
Earnings (Next)04-30 2025-04-30/amc
Inst Owners60.36%
Inst Owner Change6.26%
Ins Owners4.19%
Ins Owner Change-3.83%
Market Cap3.09B
Analysts83.16
Price Target14.28 (-11.36%)
Short Float %7.4%
Short Ratio4.67
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.15%
Min EPS beat(2)3.21%
Max EPS beat(2)13.1%
EPS beat(4)3
Avg EPS beat(4)4.47%
Min EPS beat(4)-10.04%
Max EPS beat(4)13.1%
EPS beat(8)6
Avg EPS beat(8)8.31%
EPS beat(12)9
Avg EPS beat(12)13.5%
EPS beat(16)10
Avg EPS beat(16)-4.91%
Revenue beat(2)2
Avg Revenue beat(2)2.16%
Min Revenue beat(2)1.79%
Max Revenue beat(2)2.53%
Revenue beat(4)4
Avg Revenue beat(4)3.15%
Min Revenue beat(4)1.79%
Max Revenue beat(4)4.75%
Revenue beat(8)7
Avg Revenue beat(8)2.39%
Revenue beat(12)11
Avg Revenue beat(12)3.1%
Revenue beat(16)15
Avg Revenue beat(16)4.24%
PT rev (1m)0%
PT rev (3m)8.45%
EPS NQ rev (1m)1.1%
EPS NQ rev (3m)0.55%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.15%
Revenue NQ rev (1m)0.05%
Revenue NQ rev (3m)0.29%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.15%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.14
P/FCF N/A
P/OCF 88.82
P/B 30.93
P/tB 51.07
EV/EBITDA N/A
EPS(TTM)-0.68
EYN/A
EPS(NY)-0.52
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)0.18
OCFY1.13%
SpS14.1
BVpS0.52
TBVpS0.32
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -16.37%
ROE -128.23%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 10.97%
FCFM N/A
ROA(3y)-21.65%
ROA(5y)-20.54%
ROE(3y)-95.11%
ROE(5y)-84.8%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.14%
GM growth 5Y-2.77%
F-Score5
Asset Turnover3.46
Health
Industry RankSector Rank
Debt/Equity 3.22
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 153.05%
Cap/Sales 1.53%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.88
Quick Ratio 1.88
Altman-Z 4.35
F-Score5
WACC8.95%
ROIC/WACCN/A
Cap/Depr(3y)151.69%
Cap/Depr(5y)136.01%
Cap/Sales(3y)1.72%
Cap/Sales(5y)1.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%36%
EPS Next Y24.25%
EPS Next 2Y18.4%
EPS Next 3Y29.96%
EPS Next 5Y27.53%
Revenue 1Y (TTM)48.25%
Revenue growth 3Y32.29%
Revenue growth 5Y28.99%
Sales Q2Q%50.68%
Revenue Next Year29.89%
Revenue Next 2Y26.48%
Revenue Next 3Y23.74%
Revenue Next 5Y23.58%
EBIT growth 1Y21.11%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year140.02%
EBIT Next 3Y46.92%
EBIT Next 5YN/A
FCF growth 1Y93.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y158.75%
OCF growth 3YN/A
OCF growth 5Y30.43%